Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Classifica tra le azioni #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Prezzo delle azioni
$240.45
Capitalizzazione di mercato
$579.46B
Variazione (1 giorno)
0.51%
Variazione (1 anno)
46.88%
Paese
US
Scambia Johnson & Johnson (JNJ)

Categoria

Utile per Johnson & Johnson (JNJ)
Utile nel Dec 2025 TTM: $32.58B
Secondo gli ultimi rapporti finanziari di Johnson & Johnson, gli utili attuali della società sono $32.58B. Nel 2024, la società ha registrato un utile di $16.69B, un aumento rispetto a agli utili del 2023, che erano di $15.06B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Johnson & Johnson dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $32.58B 0.00%
2025 $32.58B 95.25%
2024 $16.69B 10.79%
2023 $15.06B -21.46%
2022 $19.18B 16.25%
2021 $16.50B -4.80%
2019 $17.33B -3.73%
2018 $18.00B 1.84%
2017 $17.67B -10.76%
2016 $19.80B 3.16%
2015 $19.20B -6.65%
2014 $20.56B 32.91%
2013 $15.47B 12.31%
2012 $13.78B 11.44%
2011 $12.36B -27.06%
2010 $16.95B 7.57%
2009 $15.76B -6.93%
2008 $16.93B 27.45%
2007 $13.28B -8.94%
2006 $14.59B 11.22%
2005 $13.12B 6.37%
2004 $12.33B 19.63%
2003 $10.31B 10.95%
2002 $9.29B 17.64%
2001 $7.90B 15.00%
2000 $6.87B 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$25.73B -21.03%
US
$6.60B -79.75%
US
$16.35B -49.81%
CH
$12.40B -61.93%
GB
$21.07B -35.34%
US